Glaucoma Trial, Recruiting (NCT06227611)

Glaucoma Trial, Recruiting NCT06227611 Sponsor: Fondazione G.B. Bietti, IRCCS Condition: Glaucoma

Printed from Voxsanity (voxsanity.com.au) — NCT06227611 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Glaucoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with glaucoma that has caused damage to the nerve at the back of your eye (optic nerve) and thinning of a specific layer of cells in your eye (ganglion cell layer)

Who may not be able to join:

You are under 18 years of age
You are unable to read, understand, or sign a written consent form
You are unable to complete a visual field test (a test that checks your range of vision)
Your glaucoma is considered advanced, based on a specific measurement of the optic nerve called the cup-to-disc ratio being greater than 0.7 (confirm with trial site)
You have another condition causing damage to your optic nerve that is not glaucoma
You have a disease affecting your retina or the central part of your eye (macula)
You have cloudiness or opacities in your lens or cornea (the front surface of your eye)
You have a strong short-sightedness or long-sightedness prescription (more than ±6 units)
You have a significant astigmatism prescription (more than ±3 units)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06227611

Sponsor: Fondazione G.B. Bietti, IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Glaucoma

More information: https://clinicaltrials.gov/study/NCT06227611

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with glaucoma that has caused damage to the nerve at the back of your eye (optic nerve) and thinning of a specific layer of cells in your eye (ganglion cell layer)

Who may not be able to join:

You are under 18 years of age
You are unable to read, understand, or sign a written consent form
You are unable to complete a visual field test (a test that checks your range of vision)
Your glaucoma is considered advanced, based on a specific measurement of the optic nerve called the cup-to-disc ratio being greater than 0.7 (confirm with trial site)
You have another condition causing damage to your optic nerve that is not glaucoma
You have a disease affecting your retina or the central part of your eye (macula)
You have cloudiness or opacities in your lens or cornea (the front surface of your eye)
You have a strong short-sightedness or long-sightedness prescription (more than ±6 units)
You have a significant astigmatism prescription (more than ±3 units)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione G.B. Bietti, IRCCS

Registry

ClinicalTrials.gov

Start date

4 May 2021

Est. completion

4 May 2022

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov